Pity the genomic scientist who specializes in biomarker development, a discipline that is still being built around next-generation sequencing (NGS). This new discipline, which could be called ...

One of the primary objectives for the application of flow cytometry in any testing environment should be measurement assurance, i.e., the generation of reliable and reproducible results. This goal can ...

The key statistical objective in IVD device evaluation is establishing performance criteria while minimizing bias and maximizing precision. While the statistical considerations and methodologies ...

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Process Validation with Qualification Training Course" conference has been added to ResearchAndMarkets.com's offering. Attending this invaluable two-day ...

Biomarker development is hardly coextensive with drug development, but in every developmental stage—from exploratory research to clinical trial to therapeutic application—there is significant overlap.

A tumour biomarker is a characteristic that is objectively measured and evaluated in tumour samples as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to ...

The recent rise to prominence of clinically beneficial immune-based therapies, particularly for cancer patients, has put critical emphasis on the need for validated bio-assays measuring functional ...

Trust Vault gives life science labs one place to track key records, approvals, and system changes, keeping compliance work continuous and audit--ready. KITCHENER, ON, April 16, 2026 /PRNewswire-PRWeb/ ...

Market opportunities include enhancing medical device quality through robust process validation training, aligning with regulatory and QMS needs, and integrating GAMPv for improved data integrity.